Dr. Iona Heath, former president of the Royal College of General Practitioners (RCGP), has generated significant backlash for her assertion that Attention Deficit Hyperactivity Disorder (ADHD) is "certainly not a medical condition." The remarks were made in promotional material for an upcoming Channel 4 documentary titled "The Great ADHD Myth?"
Heath, who served as a London GP for over 35 years, challenged the conventional understanding of ADHD, which the National Health Service (NHS) describes as a condition where the brain functions differently, often leading to difficulties with concentration and remaining still. Many healthcare professionals categorize it as a neurodevelopmental disorder.
The RCGP, representing 53,000 UK GPs, has publicly distanced itself from Heath's statement, emphasizing that it does not represent the college's official stance. In a statement, the RCGP affirmed its recognition of ADHD as a neurodevelopmental condition and its support for evidence-based care in line with national guidance.
Heath, however, responded to the RCGP's swift reaction, telling GP magazine Pulse that the college's leadership should not comment before viewing the documentary. She suggested that the organization's response was premature and a reaction to publicity-driven material.
The documentary is set to feature perspectives from a number of senior NHS medical experts who are reportedly questioning the established narrative around ADHD. According to Channel 4, the film will explore whether environmental factors, as well as inflexible health and schooling systems, contribute to the behaviors associated with ADHD.
Dr. Max Pemberton, a psychiatrist and health columnist, is presenting the documentary. He noted a shift in ADHD diagnoses from rare occurrences after careful assessment to what he describes as increasingly "demanded and dispensed." While acknowledging that individuals seeking diagnosis are genuinely struggling, Pemberton stated the film aims to question whether ADHD is the most accurate explanation for these struggles.
These discussions occur against a backdrop of rapidly increasing ADHD diagnoses and medication prescriptions in England. NHS figures indicate a record 427,000 individuals were taking medication for ADHD in the past year, a 31% increase from the previous year and more than triple the number in 2016-17. Notably, the largest increase was among adults aged 18 and over, who saw a 40% rise in prescriptions.
Dr. Sami Timimi, a consultant child and adolescent psychiatrist, is quoted in promotional material suggesting that "We've replaced corporal punishment with giving [children] a pill." The largest group of children receiving ADHD medication are those between the ages of ten and fourteen.
Concerns have also been raised regarding potential serious side effects of ADHD medications. Earlier this month, campaigners warned that patients starting stimulant ADHD drugs may have undiagnosed heart defects, which affect approximately one in 300 people, potentially leading to complications. This warning follows an inquest last year that linked the stimulant medication Elvanse (lisdexamfetamine) to the sudden cardiac death of a 28-year-old finance worker who had been diagnosed with ADHD six months prior.